Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

10x Genomics (TXG) Leases (2020 - 2025)

10x Genomics' Leases history spans 6 years, with the latest figure at $60.4 million for Q4 2025.

  • For Q4 2025, Leases rose 5.52% year-over-year to $60.4 million; the TTM value through Dec 2025 reached $60.4 million, up 5.52%, while the annual FY2025 figure was $60.4 million, 5.52% up from the prior year.
  • Leases for Q4 2025 was $60.4 million at 10x Genomics, down from $63.6 million in the prior quarter.
  • Across five years, Leases topped out at $75.7 million in Q1 2022 and bottomed at $54.1 million in Q2 2021.
  • The 5-year median for Leases is $62.8 million (2024), against an average of $64.3 million.
  • The largest annual shift saw Leases surged 35.66% in 2022 before it decreased 15.91% in 2024.
  • A 5-year view of Leases shows it stood at $60.9 million in 2021, then rose by 14.71% to $69.9 million in 2022, then decreased by 6.47% to $65.4 million in 2023, then fell by 12.35% to $57.3 million in 2024, then increased by 5.52% to $60.4 million in 2025.
  • Per Business Quant, the three most recent readings for TXG's Leases are $60.4 million (Q4 2025), $63.6 million (Q3 2025), and $62.7 million (Q2 2025).